...
首页> 外文期刊>European review for medical and pharmacological sciences. >LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p
【24h】

LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p

机译:lncrana hanr通过中介miRNA-140-5p加剧了非小细胞肺癌的进展

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: The aim of this study was to elucidate the function of long non-coding ribonucleic acids (lncRNAs) HANR in aggravating non-small cell lung cancer (NSCLC) progression via targeting microRNA-140-5p (miRNA-140-5p). PATIENTS AND METHODS: The relative expression level of HANR in NSCLC tissues and cell lines was determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The correlation between HANR expression and the prognosis of NSCLC was analyzed. The regulatory effects of HANR on cellular behaviors of NSCLC cells were evaluated by Cell Counting Kit-8 (CCK-8), transwell and wound healing assay. Meanwhile, the relative expression of miRNA-140-5p in NSCLC tissues and cell lines was determined by qRT-PCR. In addition, rescue experiments were carried out to evaluate the potential influence of HANR/miRNA-140-5p on the progression of NSCLC. RESULTS: HANR expression was significantly up-regulated in NSCLC tissues and cell lines. HANR expression was positively correlated with lymphatic metastasis and distant metastasis of NSCLC patients, whereas it was negatively correlated with the overall survival of NSCLC patients. Knockdown of HANR markedly suppressed the proliferative, migratory and invasive abilities of NSCLC cells. In NSCLC tissues, the miRNA-140-5p level was negatively associated with HANR level. Furthermore, inhibited cellular behaviors of NSCLC cells transfected with sh-HANR were partially reversed after miRNA-140-5p knockdown. CONCLUSIONS: LncRNA HANR accelerates the proliferative, migratory and invasive abilities of NSCLC via negatively mediating miRNA-140-5p. Furthermore, HANR is closely correlated with lymphatic metastasis, distant metastasis and poor prognosis of NSCLC.
机译:目的:本研究的目的是通过靶向MicroRNA-140-5P(miRNA-140-5P)来阐明长期非编码核糖核酸(LNCRNA)HANR在加重非小细胞肺癌(NSCLC)进展中的功能。患者和方法:通过定量实时 - 聚合酶链反应(QRT-PCR)测定NSCLC组织和细胞系中HANR的相对表达水平。分析了HANR表达与NSCLC预后的相关性。通过细胞计数试剂盒-8(CCK-8),Transwell和伤口愈合测定,评估HANR对NSCLC细胞细胞行为的调节作用。同时,通过QRT-PCR测定了NSCLC组织和细胞系中miRNA-140-5p的相对表达。此外,进行了救援实验,以评估HANR / miRNA-140-5P对NSCLC进展的潜在影响。结果:HANR表达在NSCLC组织和细胞系中显着上调。 HANR表达与NSCLC患者的淋巴结转移和远处转移呈正相关,而它与NSCLC患者的整体存活率呈负相关。 HANR的敲低明显抑制了NSCLC细胞的增殖性,迁移和侵袭能力。在NSCLC组织中,MiRNA-140-5P水平与HANR水平负相关。此外,在MiRNA-140-5P敲低后,抑制用SH-HANR转染的NSCLC细胞的细胞行为在miRNA-140-5P敲低后部分反转。结论:LNCRNA HANR通过负介质MiRNA-140-5P加速NSCLC的增殖性,迁移和侵袭能力。此外,HANR与淋巴结转移,远距离转移和NSCLC预后差密相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号